EE9700055A - Antiöstrogeensed bensotiofenüülühendid - Google Patents

Antiöstrogeensed bensotiofenüülühendid

Info

Publication number
EE9700055A
EE9700055A EE9700055A EE9700055A EE9700055A EE 9700055 A EE9700055 A EE 9700055A EE 9700055 A EE9700055 A EE 9700055A EE 9700055 A EE9700055 A EE 9700055A EE 9700055 A EE9700055 A EE 9700055A
Authority
EE
Estonia
Prior art keywords
antiestrogenic
benzothiophenyl
compounds
benzothiophenyl compounds
antiestrogenic benzothiophenyl
Prior art date
Application number
EE9700055A
Other languages
English (en)
Other versions
EE03386B1 (et
Inventor
Smith Labell Elizabeth
Douglas Luke Wayne
John Mcneill Mcgill, Iii
Scot Miller Randal
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26976194&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE9700055(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/308,325 external-priority patent/US5629425A/en
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of EE9700055A publication Critical patent/EE9700055A/et
Publication of EE03386B1 publication Critical patent/EE03386B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EE9700055A 1994-09-19 1995-09-19 Mittesolvateerunud kristalliline 6-hüdroksü-2-(4-hüdroksüfenüül)-3-[4-(2-piperidüületoksü)bensoüül]-benso[b]tiofeenvesinik kloriid ja farmatseutiline kompositsioon EE03386B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/308,325 US5629425A (en) 1994-09-19 1994-09-19 Haloalkyl hemisolvates of 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-piperidinoethoxy)-benzoyl]benzo[b]thiophene
US42791495A 1995-04-26 1995-04-26
PCT/US1995/011872 WO1996009045A1 (en) 1994-09-19 1995-09-19 Antiestrogenic benzothiophenyl compounds

Publications (2)

Publication Number Publication Date
EE9700055A true EE9700055A (et) 1997-08-15
EE03386B1 EE03386B1 (et) 2001-04-16

Family

ID=26976194

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700055A EE03386B1 (et) 1994-09-19 1995-09-19 Mittesolvateerunud kristalliline 6-hüdroksü-2-(4-hüdroksüfenüül)-3-[4-(2-piperidüületoksü)bensoüül]-benso[b]tiofeenvesinik kloriid ja farmatseutiline kompositsioon

Country Status (51)

Country Link
US (4) US5731327A (et)
JP (2) JPH08193081A (et)
KR (2) KR100367376B1 (et)
CN (2) CN1068324C (et)
AP (1) AP754A (et)
AT (2) AT407988B (et)
AU (3) AU691955B2 (et)
BE (2) BE1009626A3 (et)
BG (1) BG62793B1 (et)
BR (2) BR9504059A (et)
CA (2) CA2158400C (et)
CH (3) CH691478A5 (et)
CO (2) CO4410191A1 (et)
CZ (2) CZ292007B6 (et)
DE (3) DE19534744A1 (et)
DK (4) DK175897B1 (et)
EE (1) EE03386B1 (et)
EG (1) EG23763A (et)
ES (2) ES2109882B1 (et)
FI (2) FI121424B (et)
FR (2) FR2732020B1 (et)
GB (2) GB2293602B (et)
GE (1) GEP19991821B (et)
GR (2) GR1002697B (et)
HK (1) HK1019009A1 (et)
HR (2) HRP950482B1 (et)
HU (2) HU225417B1 (et)
IE (2) IE950722A1 (et)
IL (3) IL125283A (et)
IS (1) IS1788B (et)
IT (2) IT1277601B1 (et)
LU (2) LU88661A1 (et)
LV (2) LV11177B (et)
MY (1) MY116371A (et)
NL (2) NL1001194C2 (et)
NO (2) NO313996B1 (et)
NZ (2) NZ280028A (et)
OA (1) OA10406A (et)
PE (2) PE14796A1 (et)
PL (2) PL182450B1 (et)
PT (2) PT101771B (et)
RO (2) RO115260B1 (et)
RS (2) RS49513B (et)
SE (2) SE520721C2 (et)
SI (2) SI9500293A (et)
SK (1) SK283502B6 (et)
TR (1) TR199501136A2 (et)
TW (1) TW412534B (et)
UA (2) UA44240C2 (et)
UY (1) UY24040A1 (et)
WO (1) WO1996009045A1 (et)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE38968E1 (en) 1992-07-28 2006-02-07 Eli Lilly And Company Methods for inhibiting bone loss using 6-hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl-4-[2-(piperidin-1-yl) ethoxyphenylimethanone hydrochloride
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
USRE39049E1 (en) 1992-07-28 2006-03-28 Eli Lilly And Company Methods for inhibiting bone loss
US5478847A (en) 1994-03-02 1995-12-26 Eli Lilly And Company Methods of use for inhibiting bone loss and lowering serum cholesterol
CO4410191A1 (es) * 1994-09-19 1997-01-09 Lilly Co Eli SINTESIS DE 3-[4-(2-AMINOETOXI)BENZOIL]-2-ARIL-6- HIDROXIBENZO [b] TIOFENOS
US6458811B1 (en) * 1996-03-26 2002-10-01 Eli Lilly And Company Benzothiophenes formulations containing same and methods
DE69739855D1 (de) * 1996-03-26 2010-06-02 Lilly Co Eli Benzothiophene und denen enthaltende zusammensetzungen
ZA979723B (en) 1996-10-30 1999-07-29 Lilly Co Eli Methods of preventing breast cancer.
CA2236254A1 (en) * 1997-04-30 1998-10-30 David Warren Hoard Process for preparing benzo¬b|thiophenes
AU777770C (en) 1999-05-04 2005-11-10 Strakan International Limited Androgen glycosides and androgenic activity thereof
US6921827B2 (en) * 2000-11-27 2005-07-26 Eli Lilly And Company Process for preparing 3-aryl-benzo{b} thiophenes
EP2266590A3 (en) 2002-02-22 2011-04-20 Shire LLC Active agent delivery sytems and methods for protecting and administering active agents
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
ATE541840T1 (de) * 2002-09-30 2012-02-15 Gea Farmaceutisk Fabrik As Raloxifene-l-lactat oder ein hemihydrat davon, deren verwendungen, pharmazeutischen zusammensetzungen und herstellungsverfahren
US6861422B2 (en) 2003-02-26 2005-03-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
US20060106010A1 (en) * 2003-05-27 2006-05-18 Black Larry J Methods for inhibiting bone loss
US7501426B2 (en) 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004029784A1 (de) 2004-06-21 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
DE102004030502A1 (de) 2004-06-24 2006-01-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Imidazole und Triazole, deren Herstellung und Verwendung als Arzneimittel
DE102004033670A1 (de) 2004-07-09 2006-02-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Pyridodihydropyrazinone, Verfahren zu Ihrer Herstellung und Ihre Verwendung als Arzneimittel
US20060035903A1 (en) 2004-08-14 2006-02-16 Boehringer Ingelheim International Gmbh Storage stable perfusion solution for dihydropteridinones
US20060074088A1 (en) 2004-08-14 2006-04-06 Boehringer Ingelheim International Gmbh Dihydropteridinones for the treatment of cancer diseases
US7759485B2 (en) 2004-08-14 2010-07-20 Boehringer Ingelheim International Gmbh Process for the manufacture of dihydropteridinones
US20060058311A1 (en) 2004-08-14 2006-03-16 Boehringer Ingelheim International Gmbh Combinations for the treatment of diseases involving cell proliferation
US7728134B2 (en) 2004-08-14 2010-06-01 Boehringer Ingelheim International Gmbh Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
EP1630163A1 (de) 2004-08-25 2006-03-01 Boehringer Ingelheim Pharma GmbH & Co.KG Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
SG155996A1 (en) 2004-09-29 2009-10-29 Bayer Schering Pharma Ag Thermodynamically stable form of bay 43-9006 tosylate
US20060068010A1 (en) * 2004-09-30 2006-03-30 Stephen Turner Method for improving the bioavailability of orally delivered therapeutics
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102004058337A1 (de) 2004-12-02 2006-06-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung von annelierten Piperazin-2-on Derivaten
DE102005035891A1 (de) 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
US7439358B2 (en) 2006-02-08 2008-10-21 Boehringer Ingelheim International Gmbh Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
MX2008014024A (es) 2006-05-04 2008-11-14 Boehringer Ingelheim Int Formas poliformas.
AR062927A1 (es) 2006-10-11 2008-12-17 Bayer Healthcare Ag 4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada
GB2456096B (en) * 2006-10-17 2011-08-17 Cipla Ltd Crystalline form of benzothiophene compound and process for preparation thereof
US20080103295A1 (en) * 2006-10-25 2008-05-01 David Losan Ho Process for the preparation of sucrose-6-ester by esterification in the presence of solid superacid catalyst
US8258291B2 (en) * 2006-10-25 2012-09-04 Mamtek International Limited Process for the preparation of sucralose by the chlorination of sugar with triphosgene (BTC)
DE102007032451B4 (de) 2007-07-12 2010-09-30 Icfs Gmbh Verfahren zur Herstellung von aromatischen Ketonen
WO2009015004A1 (en) * 2007-07-20 2009-01-29 King Pharmaceuticals Research And Development, Inc. Crystals of (2-amino-4,5,6,7-tetrahydrobenzo[b]thien-3-yl)(4-chlorophenyl)methanone
US8329695B2 (en) 2007-08-03 2012-12-11 Boehringer Ingelheim International Gmbh Crystalline form of the free base N-[trans-4-[4-(cyclopropylmethyl)-1-piperazinyl]cyclohexyl]-4-[[(7r)-7-ethyl-5,6,7,8-tetrahydro-5-methyl-8-(1-methylethyl)-6-oxo-2-pteridinyl]amino]-3-methoxy-benzamide
CL2008003799A1 (es) * 2007-12-21 2009-12-18 Synthon Bv Composicion farmaceutica que comprende raloxifeno en forma de tableta de liberacion inmediata; util para el tratamiento y/o prevencion de la osteoporosis.
PE20091730A1 (es) 2008-04-03 2009-12-10 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
US20110088613A1 (en) * 2008-06-09 2011-04-21 Massimo Ferrari Process for controlling the growth of a raloxifene hydrochloride crystal
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
BRPI0916997A2 (pt) 2008-08-06 2020-12-15 Boehringer Ingelheim International Gmbh Inibidor de dpp-4 e seu uso
US8513264B2 (en) 2008-09-10 2013-08-20 Boehringer Ingelheim International Gmbh Combination therapy for the treatment of diabetes and related conditions
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
CN107011345A (zh) 2008-12-23 2017-08-04 勃林格殷格翰国际有限公司 有机化合物的盐形式
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
ES2437916T3 (es) 2009-07-02 2014-01-15 Synthon B.V. Composición de raloxifeno
EP2314581B1 (en) 2009-10-23 2012-07-25 Hexal AG A process for preparing benzo[b]thiophene derivatives
EP3646859A1 (en) 2009-11-27 2020-05-06 Boehringer Ingelheim International GmbH Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
WO2011099942A1 (en) 2010-02-09 2011-08-18 Silverstone Pharma New addition salts of raloxifene, process for the preparation thereof and use thereof in therapy
AU2011249722B2 (en) 2010-05-05 2015-09-17 Boehringer Ingelheim International Gmbh Combination therapy
BR112012032579B1 (pt) 2010-06-24 2021-05-11 Boehringer Ingelheim International Gmbh uso de linagliptina e composição farmacêutica compreendendo linagliptina e insulina basal de longa duração
US8546566B2 (en) 2010-10-12 2013-10-01 Boehringer Ingelheim International Gmbh Process for manufacturing dihydropteridinones and intermediates thereof
IT1403083B1 (it) * 2010-10-25 2013-10-04 Fidia Farmaceutici Nuova forma polimorfa di raloxifene cloridrato
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
US9358233B2 (en) 2010-11-29 2016-06-07 Boehringer Ingelheim International Gmbh Method for treating acute myeloid leukemia
US9370535B2 (en) 2011-05-17 2016-06-21 Boehringer Ingelheim International Gmbh Method for treatment of advanced solid tumors
HUE043540T2 (hu) 2011-07-15 2019-08-28 Boehringer Ingelheim Int Szubsztituált dimer kinazolin-származék, elõállítása, valamint alkalmazása 1-es és 2-es típusú cukorbetegség kezelésére szolgáló gyógyászati készítményekben
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
EP3685839A1 (en) 2012-05-14 2020-07-29 Boehringer Ingelheim International GmbH Linagliptin for use in the treatment of albuminuria and kidney related diseases
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
IN2013MU00665A (et) 2013-03-05 2015-07-03 Cipla Ltd
US20150031699A1 (en) 2013-07-26 2015-01-29 Boehringer Ingelheim International Gmbh Treatment of myelodysplastic syndrome
ES2950384T3 (es) 2014-02-28 2023-10-09 Boehringer Ingelheim Int Uso médico de un inhibidor de DPP-4
US9867831B2 (en) 2014-10-01 2018-01-16 Boehringer Ingelheim International Gmbh Combination treatment of acute myeloid leukemia and myelodysplastic syndrome
CN104496963A (zh) * 2014-12-02 2015-04-08 千辉药业（安徽）有限责任公司 一种盐酸雷洛昔芬的制备方法
BR112018072401A2 (pt) 2016-06-10 2019-02-19 Boehringer Ingelheim International Gmbh combinações de linagliptina e metformina

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3869485A (en) * 1969-09-25 1975-03-04 Allied Chem Preparation of acid chlorides with phosgene in the presence of a catalyst
GB1456323A (en) * 1974-06-06 1976-11-24 Labaz Benzothiophenes process for preparing them and pharmaceutical compositions containing the same
US4133814A (en) 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4358593A (en) 1981-04-03 1982-11-09 Eli Lilly And Company Process for preparing 3-(4-aminoethoxybenzoyl)benzo[b]thiophenes
IL65379A0 (en) * 1981-04-03 1982-05-31 Lilly Co Eli Process for preparing acylated benzothiophenes
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
EP0062503A1 (en) 1981-04-03 1982-10-13 Eli Lilly And Company Benzothiophene compounds and process for preparing them
IL65378A (en) * 1981-04-03 1986-02-28 Lilly Co Eli Process for preparing 3-(4-aminoethoxybenzoyl)benzo-(b)thiophenes
ZA822247B (en) 1981-04-03 1983-11-30 Lilly Co Eli Benzothiophene compounds and process for preparing them
DE4117512A1 (de) * 1991-05-25 1992-11-26 Schering Ag 2-phenylbenzo(b)furane und -thiophene, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
US5169860A (en) 1992-03-13 1992-12-08 Eli Lilly And Company Antitumor compositions and methods of treatment
TW383306B (en) * 1992-12-22 2000-03-01 Lilly Co Eli New use of 2-phenyl-3-aroylbenzothiophenes in lowering serum cholesterol
ES2105525T3 (es) 1993-06-24 1997-10-16 Lilly Co Eli 2-fenil-3-aroilbenzotiofenos antiestrogenicos como agentes hipoglicemicos.
US6756388B1 (en) 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
US5523416A (en) 1994-07-22 1996-06-04 Eli Lilly And Company Process for preparing 3-(4-aminoethoxy-benzoyl) benzo (B)-thiophenes
CO4410191A1 (es) * 1994-09-19 1997-01-09 Lilly Co Eli SINTESIS DE 3-[4-(2-AMINOETOXI)BENZOIL]-2-ARIL-6- HIDROXIBENZO [b] TIOFENOS

Also Published As

Publication number Publication date
ES2109882A1 (es) 1998-01-16
RO115260B1 (ro) 1999-12-30
NO953658D0 (no) 1995-09-15
FI121424B (fi) 2010-11-15
PL187686B1 (pl) 2004-09-30
DK102795A (da) 1996-03-20
CZ240395A3 (en) 1996-04-17
CA2158400A1 (en) 1996-03-20
HK1019009A1 (en) 2000-01-14
AP9700938A0 (en) 1997-04-30
CZ292007B6 (cs) 2003-07-16
US20020173645A1 (en) 2002-11-21
FI954402A0 (fi) 1995-09-18
PL182450B1 (pl) 2002-01-31
AU3173095A (en) 1996-04-04
NO308107B1 (no) 2000-07-24
TR199501136A2 (tr) 1996-06-21
BG62793B1 (bg) 2000-08-31
NL1001196A1 (nl) 1996-03-19
SE520721C2 (sv) 2003-08-12
MY116371A (en) 2004-01-31
DE19534745A1 (de) 1996-04-04
HRP950483A2 (en) 1997-10-31
CN1068324C (zh) 2001-07-11
NO953657L (no) 1996-03-20
BG101242A (en) 1998-03-31
RO115259B1 (ro) 1999-12-30
AU691955B2 (en) 1998-05-28
DE19534745B4 (de) 2004-06-09
CN1127253A (zh) 1996-07-24
LV11177A (lv) 1996-04-20
YU61495A (sh) 1998-05-15
GB2293382A (en) 1996-03-27
RS49513B (sr) 2006-10-27
CO4410191A1 (es) 1997-01-09
TW412534B (en) 2000-11-21
HUT74178A (en) 1996-11-28
US6472531B1 (en) 2002-10-29
NL1001196C2 (nl) 1997-04-04
PL310518A1 (en) 1996-04-01
DK175897B1 (da) 2005-05-30
IL115315A0 (en) 1995-12-31
JP2860071B2 (ja) 1999-02-24
BE1009625A3 (fr) 1997-06-03
RS49578B (sr) 2007-04-10
OA10406A (en) 2001-12-05
FI954403A0 (fi) 1995-09-18
ATA154295A (de) 2000-12-15
HU227683B1 (en) 2011-11-28
GR1002709B (el) 1997-06-04
LU88661A1 (fr) 1996-07-15
PT101771B (pt) 1997-04-30
SE9503214D0 (sv) 1995-09-15
SI9500292A (en) 1996-06-30
DK175886B1 (da) 2005-05-23
JPH08176147A (ja) 1996-07-09
HU9502721D0 (en) 1995-11-28
CA2158399A1 (en) 1996-03-20
PT101770B (pt) 1997-04-30
SK23397A3 (en) 1997-08-06
UY24040A1 (es) 1996-03-07
NO953658L (no) 1996-03-20
FR2724655A1 (fr) 1996-03-22
EG23763A (en) 2007-08-08
IS1788B (is) 2001-11-28
LV11178A (lv) 1996-04-20
NL1001194C2 (nl) 1997-04-04
GB9519028D0 (en) 1995-11-15
IE950721A1 (en) 1996-03-20
WO1996009045A1 (en) 1996-03-28
IE950722A1 (en) 1996-03-20
CN1075069C (zh) 2001-11-21
SE9503213D0 (sv) 1995-09-15
GB2293602B (en) 1998-05-06
NL1001194A1 (nl) 1996-03-19
EE03386B1 (et) 2001-04-16
NZ280027A (en) 1997-05-26
IT1277602B1 (it) 1997-11-11
AU3718695A (en) 1996-04-09
ES2129293B1 (es) 2000-01-16
CN1132205A (zh) 1996-10-02
PE32796A1 (es) 1996-08-07
KR960010634A (ko) 1996-04-20
FR2732020B1 (fr) 1997-11-14
GB2293382B (en) 1998-08-19
IL115314A (en) 2000-02-29
PT101770A (pt) 1996-04-30
ITMI951935A1 (it) 1997-03-15
HU9502723D0 (en) 1995-11-28
GEP19991821B (en) 1999-11-05
CZ290343B6 (cs) 2002-07-17
DK2797A (da) 1997-01-09
IL115314A0 (en) 1996-05-14
US5731327A (en) 1998-03-24
FI954402A (fi) 1996-03-20
CH691125A5 (de) 2001-04-30
PL310517A1 (en) 1996-04-01
IS4446A (is) 1997-03-18
CA2158399C (en) 2001-03-20
LV11178B (en) 1996-08-20
CH691594A5 (de) 2001-08-31
AU3173195A (en) 1996-04-04
KR100367376B1 (ko) 2003-03-06
ES2129293A1 (es) 1999-06-01
UA44240C2 (uk) 2002-02-15
CH691478A5 (de) 2001-07-31
HU225417B1 (en) 2006-11-28
FI954403A (fi) 1996-03-20
HRP950482B1 (en) 2007-04-30
PE14796A1 (es) 1996-05-19
GR1002697B (el) 1997-05-22
DK2897A (da) 1997-01-09
NZ280028A (en) 1997-05-26
GB2293602A (en) 1996-04-03
IE80883B1 (en) 1999-05-19
SE9503213L (sv) 1996-03-20
AU692907B2 (en) 1998-06-18
HUT75033A (en) 1997-03-28
KR960010637A (ko) 1996-04-20
AP754A (en) 1999-07-22
SE9503214L (sv) 1996-03-20
SK283502B6 (sk) 2003-08-05
ES2109882B1 (es) 1998-08-16
UA42716C2 (uk) 2001-11-15
AT407988B (de) 2001-07-25
JPH08193081A (ja) 1996-07-30
CZ240295A3 (en) 1996-04-17
PT101771A (pt) 1996-04-30
HRP950483B1 (en) 2003-02-28
US6399778B1 (en) 2002-06-04
BE1009626A3 (fr) 1997-06-03
KR100381346B1 (ko) 2004-04-13
DK102895A (da) 1996-03-20
IT1277601B1 (it) 1997-11-11
LV11177B (en) 1996-08-20
DK175903B1 (da) 2005-06-06
DE19549755B4 (de) 2005-05-04
YU61395A (sh) 1998-09-18
IL125283A (en) 2001-06-14
ITMI951936A0 (it) 1995-09-15
FR2732020A1 (fr) 1996-09-27
HRP950482A2 (en) 1998-02-28
LU88660A1 (fr) 1996-07-15
ITMI951935A0 (it) 1995-09-15
DE19534744A1 (de) 1996-03-21
GB9519032D0 (en) 1995-11-15
FI112226B (fi) 2003-11-14
SI9500293A (en) 1996-06-30
ITMI951936A1 (it) 1997-03-15
NO953657D0 (no) 1995-09-15
IL115315A (en) 1999-09-22
FR2724655B1 (fr) 1997-11-14
AT502957A1 (de) 2007-06-15
BR9504060A (pt) 1996-09-24
NO313996B1 (no) 2003-01-13
SE509265C2 (sv) 1998-12-21
CO4410190A1 (es) 1997-01-09
CA2158400C (en) 2006-10-24
BR9504059A (pt) 1996-09-24
DK175887B1 (da) 2005-05-23

Similar Documents

Publication Publication Date Title
EE9700055A (et) Antiöstrogeensed bensotiofenüülühendid
DK0777671T3 (da) Spiro-azabicykliske forbindelser
DE59510955D1 (de) Offsetdruckmaschine
PT1047695E (pt) Novos compostos antiarritmicos de bispidina
BR9710352A (pt) Compostos piridilpirrole
DK0804344T3 (da) Stempelapparat
EE9800430A (et) Uued ühendid
BR9705635A (pt) Compostos
DE29505306U1 (de) Scheibenschneider
FI970151A0 (fi) Viruksenvastaisesti vaikuttavia difluoristatoniyhdisteitä
DE69709659D1 (de) Halopropargyl-einschlussverbindungen
DE59708995D1 (de) Esterquats
NO972257D0 (no) 18-nor-vitamin D-forbindelser
IS4932A (is) Ný efnasambönd
DE9405878U1 (de) Rhenchodepressive Substanz
SE9403728D0 (sv) New compounds
SE9402838D0 (sv) New compounds
SE9402813D0 (sv) New compounds
SE9402170D0 (sv) New compounds
SE9601787D0 (sv) New compounds
SE9604788D0 (sv) New compounds
SE9604787D0 (sv) New compounds
SE9600555D0 (sv) New compounds
SE9600554D0 (sv) New compounds
SE9604785D0 (sv) New compounds

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231